Normal pressure hydrocephalus in two Parkinson’s disease patients with deep brain stimulation – co-occurrence or complication
Objective: We here in report two patients of Parkinson disease patients who underwent DBS and developed NPH as a late event. Background: Parkinsonism manifests distinctly…The Differences in the Perception of Parkinson’s Disease-related Motor Complications between Patients and Physicians
Objective: This study aimed to evaluate the differences in the perception of Parkinson’s disease (PD)-related motor complications by utilizing questionnaires answered by both PD patients…Wilson Disease Presenting as Rapidly Progressive Dementia
Objective: To describe an atypical presentation of Wilson Disease. Background: Wilson Disease is a rare autosomal recessive disorder that causes copper accumulation in the brain…Post-stroke Movement Disorders: A Systematic Review of the Clinical Spectrum, Neuroanatomy, and Demographic Characteristics of 577 Published cases
Objective: To comprehensively examine the spectrum of post-stroke movement disorders (PSMDs), with a focus on understanding their prevalence, clinical characteristics, neuroanatomical correlates, and demographic profiles…Body Mass Index as a Possible Poor Prognostic Factor in Motor and Postural Condition Through the Evaluation of MDS-UPDRS 3.3 – 3.18 in Patients with Parkinson’s.
Objective: To determine the degree of motor and postural impairment of patients with Parkinson's Disease at the time of their first consultation according to the…Parkinsonism due to Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Responsive to Carbidopa/Levodopa
Objective: To describe a case of Parkinsonism due to ALSP which is responsive to carbidopa/levodopa Background: Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)…Parkinson Disease. An innovative Aproach
Objective: Aims: promoting maximum autonomy, potentiating resources, improve functionality, stimulating activity, preventing complications. Background: Since 2006, the Program has operated uninterruptedly, even during COVID-19. Aimed…New onset movement disorders following COVID-19 infection
Objective: To determine the prevalence and phenotype of movement disorders following SARS-CoV-2 infection in hospitalised individuals. Background: Although movement disorders, including parkinsonism, following SARS-CoV-2 (COVID-19)…PKG-Ethnicity project: An initial analysis of ethnical differences in Parkinson’s KinetoGraph (PKG) results between white and non-white ethnic groups
Objective: Using the Parkinson’s KinetiGraph (PKG) reports of PwP to determine if scores vary according to ethnicity, classed as white or non-white PwP (Black, Asian,…Inclusion of PSP-Parkinsonism (PSP-P) phenotype in clinical trials – power calculation
Objective: PSP-P is the second most common PSP phenotype. To facilitate its inclusion in future clinical trials, we used longitudinal data from the TAUROS study…
- « Previous Page
- 1
- …
- 84
- 85
- 86
- 87
- 88
- …
- 1554
- Next Page »